Downloadable Slide Decks

New Directions in the Management of Graft-Versus-Host Disease

Self-Study Resource | Nonaccredited
GVHD is a major complication of hematopoietic stem cell transplant, occurring in 40% to 60% of patients. Learn more about risk assessment, prophylaxis, and emerging data on therapeutic selection with this free slide deck presented by Mark A. Schroeder, MD.

Current Trends and Future Directions in Targeted Therapies for Advanced Renal Cell Carcinoma

1.0 CME | ILNA Points | Self-Study Resource
Watch this CME-certified discussion with Brian I. Rini, MD, FACP from Cleveland Clinic Lerner College of Medicine as he discusses emerging data on targeted therapies for the treatment of patients with advanced RCC. Speaker slides available for download.

Defining Personalized Care Plans in Metastatic Castration-Resistant Prostate Cancer

1.0 CME/CE | ILNA Points | Self-Study Resource
Watch this CME/CE-certified discussion with Tanya Dorff, MD from the Keck School of Medicine as she discusses progress in our understanding of predictive/prognostic markers in advanced prostate cancer as well as optimizing treatment sequencing and response assessment.

Selecting Optimal Therapeutic Strategies for Patients With Differentiated and Medullary Thyroid Cancer

1.0 CME | ILNA Points | Self-Study Resource
In this case-based activity, leading clinical investigator Jochen Lorch, MD, MS from Dana-Farber Cancer Institute will share insights into evidence-based personalized care planning for patients with differentiated and medullary thyroid cancer.

Optimizing Management of Relapsed/Refractory DLBCL: Applying Emerging Evidence in Practice

Self-Study Resource | Nonaccredited
This activity discusses and debates evidence-based best practices in the management of relapsed/refractory DLBCL. Review the slides today!

Nursing Strategies to Optimize Treatment Experiences in Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer

1.0 CE | Self-Study Resource
This expert-led activity will review personalized care planning for patients with MBC. Participants will learn about CDK4/6 inhibitor safety profiles and supportive care strategies to prevent and mitigate adverse events. Schedule this meeting at your institution now!

New Directions in the Management of Recurrent Ovarian Cancer: Focus on PARP Inhibitors

1.0 CME | Self-Study Resource
This activity will bring a leading clinical investigator to your cancer center to discuss emerging data on PARP inhibitors that can rationally inform the management of ovarian cancer. Enroll your institution today!

Challenges and Opportunities in Castration-Resistant Prostate Cancer

Self-Study Resource | Nonaccredited

This activity discusses emerging data on treatment selection, resistance, and response in castration-resistant prostate cancer. Review the slides today!

Clinician's Resource Guides

Optimizing the Management of Advanced Cervical Cancer With Checkpoint Inhibitor Therapy

Self-Study Resource | Nonaccredited
his case-based online activity features a discussion between leading clinical investigators, Ramez Eskander, MD and Bradley Monk, MD, FACS, FACOG, as they explore the management of advanced cervical cancer with checkpoint inhibitor therapy.

Optimizing Management of Carcinoid Syndrome in Patients With Neuroendocrine Tumors

Self-Study Resource | Nonaccredited

In this case-based activity, Pamela Ryan, RN, BSN from Ochsner Medical Center and Donna Williams, RN from Stanford Medicine discuss signs and symptoms of carcinoid syndrome in patients with NETs and the application of supportive care strategies to provide symptom relief.

Preventing and Mitigating Chemotherapy-Induced Nausea and Vomiting in High-Risk Patients

Self-Study Resource | Nonaccredited

In this case-based activity, Rebecca Clark-Snow, RN, BSN, OCN® and Una T. Hopkins, DNP discuss CINV risk assessment, emetic risk, antiemetic regimens, and self report in high-risk patients with cancer.

© Copyright 2018 i3 Health. All rights reserved.